Global Stem Cells Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Stem Cells Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

According to APO Research, The global Stem Cells market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Stem Cells, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Stem Cells, also provides the value of main regions and countries. Of the upcoming market potential for Stem Cells, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Stem Cells revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Stem Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Stem Cells company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Stem Cells segment by Company

Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Stem Cells segment by Type

Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Stem Cells segment by Application

Diseases of the Central Nervous System
Cardiovascular Disease
Diabetes
Cancer
Genetic Diseases
Autoimmune Disease
Bone and Cartilage Repair
Other
Stem Cells segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Stem Cells status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Stem Cells key companies, revenue, market share, and recent developments.
3. To split the Stem Cells breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Stem Cells market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Stem Cells significant trends, drivers, influence factors in global and regions.
6. To analyze Stem Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cells industry.
Chapter 3: Detailed analysis of Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Stem Cells in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Stem Cells Market Size, 2019 VS 2023 VS 2030
1.3 Global Stem Cells Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Stem Cells Market Dynamics
2.1 Stem Cells Industry Trends
2.2 Stem Cells Industry Drivers
2.3 Stem Cells Industry Opportunities and Challenges
2.4 Stem Cells Industry Restraints
3 Stem Cells Market by Company
3.1 Global Stem Cells Company Revenue Ranking in 2023
3.2 Global Stem Cells Revenue by Company (2019-2024)
3.3 Global Stem Cells Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Stem Cells Company Manufacturing Base & Headquarters
3.5 Global Stem Cells Company, Product Type & Application
3.6 Global Stem Cells Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Stem Cells Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Stem Cells Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Stem Cells Market by Type
4.1 Stem Cells Type Introduction
4.1.1 Stem Cell Storage
4.1.2 Stem Cell Pharmaceutical and Treatment
4.2 Global Stem Cells Sales Value by Type
4.2.1 Global Stem Cells Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Stem Cells Sales Value by Type (2019-2030)
4.2.3 Global Stem Cells Sales Value Share by Type (2019-2030)
5 Stem Cells Market by Application
5.1 Stem Cells Application Introduction
5.1.1 Diseases of the Central Nervous System
5.1.2 Cardiovascular Disease
5.1.3 Diabetes
5.1.4 Cancer
5.1.5 Genetic Diseases
5.1.6 Autoimmune Disease
5.1.7 Bone and Cartilage Repair
5.1.8 Other
5.2 Global Stem Cells Sales Value by Application
5.2.1 Global Stem Cells Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Stem Cells Sales Value by Application (2019-2030)
5.2.3 Global Stem Cells Sales Value Share by Application (2019-2030)
6 Stem Cells Market by Region
6.1 Global Stem Cells Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Stem Cells Sales Value by Region (2019-2030)
6.2.1 Global Stem Cells Sales Value by Region: 2019-2024
6.2.2 Global Stem Cells Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Stem Cells Sales Value (2019-2030)
6.3.2 North America Stem Cells Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Stem Cells Sales Value (2019-2030)
6.4.2 Europe Stem Cells Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Stem Cells Sales Value (2019-2030)
6.5.2 Asia-Pacific Stem Cells Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Stem Cells Sales Value (2019-2030)
6.6.2 Latin America Stem Cells Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Stem Cells Sales Value (2019-2030)
6.7.2 Middle East & Africa Stem Cells Sales Value Share by Country, 2023 VS 2030
7 Stem Cells Market by Country
7.1 Global Stem Cells Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Stem Cells Sales Value by Country (2019-2030)
7.2.1 Global Stem Cells Sales Value by Country (2019-2024)
7.2.2 Global Stem Cells Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.3.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.4.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.5.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.6.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.7.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.8.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.9.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.10.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.11.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.12.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.13.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.14.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.15.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.16.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.17.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.18.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.19.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.20.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Stem Cells Sales Value Growth Rate (2019-2030)
7.21.2 Global Stem Cells Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Stem Cells Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Osiris Therapeutics
8.1.1 Osiris Therapeutics Comapny Information
8.1.2 Osiris Therapeutics Business Overview
8.1.3 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2019-2024)
8.1.4 Osiris Therapeutics Stem Cells Product Portfolio
8.1.5 Osiris Therapeutics Recent Developments
8.2 NuVasive
8.2.1 NuVasive Comapny Information
8.2.2 NuVasive Business Overview
8.2.3 NuVasive Stem Cells Revenue and Gross Margin (2019-2024)
8.2.4 NuVasive Stem Cells Product Portfolio
8.2.5 NuVasive Recent Developments
8.3 Chiesi Pharmaceuticals
8.3.1 Chiesi Pharmaceuticals Comapny Information
8.3.2 Chiesi Pharmaceuticals Business Overview
8.3.3 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2019-2024)
8.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
8.3.5 Chiesi Pharmaceuticals Recent Developments
8.4 Medi-post
8.4.1 Medi-post Comapny Information
8.4.2 Medi-post Business Overview
8.4.3 Medi-post Stem Cells Revenue and Gross Margin (2019-2024)
8.4.4 Medi-post Stem Cells Product Portfolio
8.4.5 Medi-post Recent Developments
8.5 JCR Pharmaceutical
8.5.1 JCR Pharmaceutical Comapny Information
8.5.2 JCR Pharmaceutical Business Overview
8.5.3 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2019-2024)
8.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
8.5.5 JCR Pharmaceutical Recent Developments
8.6 MolMed
8.6.1 MolMed Comapny Information
8.6.2 MolMed Business Overview
8.6.3 MolMed Stem Cells Revenue and Gross Margin (2019-2024)
8.6.4 MolMed Stem Cells Product Portfolio
8.6.5 MolMed Recent Developments
8.7 Pharmicell
8.7.1 Pharmicell Comapny Information
8.7.2 Pharmicell Business Overview
8.7.3 Pharmicell Stem Cells Revenue and Gross Margin (2019-2024)
8.7.4 Pharmicell Stem Cells Product Portfolio
8.7.5 Pharmicell Recent Developments
8.8 Anterogen
8.8.1 Anterogen Comapny Information
8.8.2 Anterogen Business Overview
8.8.3 Anterogen Stem Cells Revenue and Gross Margin (2019-2024)
8.8.4 Anterogen Stem Cells Product Portfolio
8.8.5 Anterogen Recent Developments
8.9 Takeda (TiGenix)
8.9.1 Takeda (TiGenix) Comapny Information
8.9.2 Takeda (TiGenix) Business Overview
8.9.3 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2019-2024)
8.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
8.9.5 Takeda (TiGenix) Recent Developments
8.10 CBR
8.10.1 CBR Comapny Information
8.10.2 CBR Business Overview
8.10.3 CBR Stem Cells Revenue and Gross Margin (2019-2024)
8.10.4 CBR Stem Cells Product Portfolio
8.10.5 CBR Recent Developments
8.11 ViaCord
8.11.1 ViaCord Comapny Information
8.11.2 ViaCord Business Overview
8.11.3 ViaCord Stem Cells Revenue and Gross Margin (2019-2024)
8.11.4 ViaCord Stem Cells Product Portfolio
8.11.5 ViaCord Recent Developments
8.12 Esperite
8.12.1 Esperite Comapny Information
8.12.2 Esperite Business Overview
8.12.3 Esperite Stem Cells Revenue and Gross Margin (2019-2024)
8.12.4 Esperite Stem Cells Product Portfolio
8.12.5 Esperite Recent Developments
8.13 LifeCell
8.13.1 LifeCell Comapny Information
8.13.2 LifeCell Business Overview
8.13.3 LifeCell Stem Cells Revenue and Gross Margin (2019-2024)
8.13.4 LifeCell Stem Cells Product Portfolio
8.13.5 LifeCell Recent Developments
8.14 CCBC
8.14.1 CCBC Comapny Information
8.14.2 CCBC Business Overview
8.14.3 CCBC Stem Cells Revenue and Gross Margin (2019-2024)
8.14.4 CCBC Stem Cells Product Portfolio
8.14.5 CCBC Recent Developments
8.15 VCANBIO
8.15.1 VCANBIO Comapny Information
8.15.2 VCANBIO Business Overview
8.15.3 VCANBIO Stem Cells Revenue and Gross Margin (2019-2024)
8.15.4 VCANBIO Stem Cells Product Portfolio
8.15.5 VCANBIO Recent Developments
8.16 BOYA LIFE
8.16.1 BOYA LIFE Comapny Information
8.16.2 BOYA LIFE Business Overview
8.16.3 BOYA LIFE Stem Cells Revenue and Gross Margin (2019-2024)
8.16.4 BOYA LIFE Stem Cells Product Portfolio
8.16.5 BOYA LIFE Recent Developments
8.17 Beike Biotechnology
8.17.1 Beike Biotechnology Comapny Information
8.17.2 Beike Biotechnology Business Overview
8.17.3 Beike Biotechnology Stem Cells Revenue and Gross Margin (2019-2024)
8.17.4 Beike Biotechnology Stem Cells Product Portfolio
8.17.5 Beike Biotechnology Recent Developments
8.18 International Medical
8.18.1 International Medical Comapny Information
8.18.2 International Medical Business Overview
8.18.3 International Medical Stem Cells Revenue and Gross Margin (2019-2024)
8.18.4 International Medical Stem Cells Product Portfolio
8.18.5 International Medical Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings